Dietary Oxalate May Quietly Worsen IBD by Exploiting a Gut Bacteria Gap

If you have inflammatory bowel disease (IBD) and have ever felt worse after a big salad or a smoothie loaded with spinach, new research out of the University of North Carolina suggests you might not be imagining it. Scientists there have identified dietary oxalate, a naturally occurring compound in many plant foods, as a possible active driver of gut inflammation in Crohn's disease and ulcerative colitis, not just an innocent bystander. The finding points to a bacterial processing gap in the IBD gut, not a difference in what patients are eating.

Key takeaways:

• IBD patients have lower levels of the gut transporter proteins that help the body handle oxalate, and Crohn's patients had more oxalate in their stool than healthy controls despite eating similar amounts of plant food.
• In mice, adding oxalate to the diet alongside a colitis-triggering agent made them 60 percent less likely to survive than mice on a colitis-triggering diet without added oxalate.
• The researchers are not telling anyone to cut out plant foods. The findings are still observational in humans, and the authors say the results need to be confirmed in larger, longer studies before they translate into dietary advice.

Oxalate Transporters Are Suppressed in IBD Gut Tissue

Oxalate is a compound found naturally in many plants (think spinach, beets, nuts, and chocolate) that the body normally clears with help from specialized proteins and gut bacteria. In a study published August 13, 2026 in Cellular and Molecular Gastroenterology and Hepatology, researchers at UNC found that two transporter proteins responsible for moving oxalate out of the gut, SLC26A2 and SLC26A3, are consistently reduced in intestinal tissue from patients with both ulcerative colitis and Crohn's disease compared to healthy controls. The team also linked low expression of a related transporter, SLC26A6, to more severe disease: nearly 75 percent of patients with low SLC26A6 expression had stricturing disease, a complication in which scar tissue narrows the intestine. That specific link is exploratory and the authors flag it as needing confirmation in larger patient groups.

Why This Matters for Crohn's and Ulcerative Colitis Patients

For people living with IBD, the study offers a more precise explanation for a symptom pattern many already suspect: that certain "healthy" plant foods seem to make their gut worse. Using DNA metabarcoding, a genetic method for identifying exactly what foods a person actually ate, the researchers found that Crohn's disease patients were eating amounts of plant-based food similar to healthy controls, yet still had significantly higher oxalate levels in their stool. "That told us this isn't just about what patients eat," said lead author Anna Salvador, PhD, RD, a postdoctoral scholar in the Sheikh Lab at UNC. "Something is fundamentally different about how their gut handles oxalate." That points toward a missing or diminished capacity to break oxalate down, rather than patients simply overeating oxalate-rich foods.

How the Study Combined Human Tissue Data With Mouse Experiments

The study paired human observational data (gut tissue and stool from IBD patients and healthy controls, plus DNA metabarcoding of diet) with controlled mouse experiments, which is what allowed the researchers to move from an association to a causal test. In two mouse models of colitis, animals fed an oxalate-supplemented diet alongside a colitis-inducing agent were 60 percent less likely to survive than mice given the same colitis-inducing agent without the added oxalate. That causal piece is what the human data alone couldn't provide: it shows dietary oxalate can actively worsen gut inflammation, at least in mice, rather than simply appearing as a downstream marker of a sicker gut. The researchers also point to prior work showing that oxalate-degrading gut bacteria such as Oxalobacter formigenes are less common in IBD patients than in healthy people, a piece of the puzzle that fits with a bacterial processing gap rather than a pure dietary explanation. The research was funded by the Helmsley Charitable Trust, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Chan Zuckerberg Initiative, Schmidt Sciences, and the Burroughs Wellcome Fund, all nonprofit or public funders with no commercial stake in the results.

Should You Cut Back on Oxalate-Rich Foods?

Not based on this study alone, and the researchers are explicit about that. Senior author Shehzad Z. Sheikh, MD, PhD, professor of medicine and genetics at UNC, described the work as opening "a genuinely new therapeutic angle" that connects specific food compounds to gut inflammation, but the study does not establish that any particular patient should restrict oxalate-rich foods like spinach, beets, or nuts. What it does suggest is a testable hypothesis worth raising with a gastroenterologist: if you have IBD and notice your symptoms flare after oxalate-heavy meals, that pattern may have a biological basis worth discussing, rather than being unrelated to your gut's underlying transporter and microbiome function. This gut-focused finding builds on separate research linking loss of the related transporter SLC26A6 to gut microbial imbalance and barrier breakdown, reinforcing that these oxalate-handling proteins matter for gut health beyond kidney stone risk, which is where they were first studied.

Why This Isn't Ready for Dietary Guidelines Yet

The biggest caveat is that the human side of the study is observational, meaning it shows an association between low transporter expression, higher stool oxalate, and IBD, not proof that oxalate causes worse disease in people the way it did in mice. The authors state directly that before any formal clinical recommendations about dietary oxalate intake, the findings need "validation in larger, longitudinal patient cohorts that integrate stool oxalate measurements, rigorously captured dietary intake, molecular profiling and microbiome analyses." The SLC26A6-to-stricturing-disease link is also described as exploratory. In other words, this is a mechanistic lead, not a finished dietary protocol.

What Comes Next

The UNC team's next step is exactly the validation work they flagged: larger, longer-running studies that track stool oxalate, actual dietary intake, and gut microbiome composition together in IBD patients over time, rather than in a single snapshot. Longer term, the researchers see this as a "molecular framework" (Sheikh's words) for eventually tailoring dietary guidance to a patient's specific gut biology, but that kind of personalized recommendation is still a research goal, not something available to patients now.

Common Questions

Does this mean people with IBD should avoid spinach, beets, or nuts? No. The researchers explicitly did not recommend eliminating oxalate-rich plant foods; the findings still need confirmation in larger human studies before they could support specific dietary advice.

What is Oxalobacter formigenes and why does it matter here? It's a gut bacterium that specializes in breaking down oxalate. Prior research has found it's less commonly present in IBD patients than in healthy people, which fits with this study's picture of a gut that's less able to process oxalate in IBD.

Is this study just in mice, or does it apply to humans? Both. The transporter and stool-oxalate findings come from human tissue and stool samples; the 60 percent survival difference is from mouse experiments, which is what lets the researchers say oxalate can actively worsen colitis rather than just correlate with it.

Should I ask my doctor about this? If you have IBD and notice your symptoms seem to track with oxalate-rich foods, it's a reasonable thing to mention to a gastroenterologist, but there's no established clinical protocol from this study yet.

References

Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease. NIH. https://pubmed.ncbi.nlm.nih.gov/15610315/